Figure 3From: Ultrastructural changes of erythrocytes in whole blood after exposure to prospective in silico-designed anticancer agents: a qualitative case studyEx vivo haemolysis assay. The haemolytic activity of ESE-15-ol- and ESE-16-treated erythrocytes was found to be less than 1% as observed in the control samples. Standard deviation was indicated on the graph for 3 technical repeats.Back to article page